Penlon Limited will introduce the AV-S MRI anaesthesia ventilator at the World Congress of Anaesthesiologists
28th July 2016
Penlon Limited will announce further expansion of its MRI product portfolio with the introduction of the AV-S MRI anaesthesia ventilator at the World Congress of Anaesthesiologists 2016.
The AV-S MRI electronic ventilatorwith advanced spontaneous support modes, electronic PEEP, oxygen monitoring, spirometry and system integration has been designed to address the special requirements of the anaesthetist working in magnetic resonance imaging (MRI) suites.
Showcasing the company’s diverse product portfolio the Penlon stand (#805A) will feature the new slimline AV-S 12-inch remote ventilator display and the ultra compact Prima 440 anaesthetic machine.
Peter Worrallo, Penlon’s Managing Director for Sales and Business Development said:
“Penlon have been attending the World Congress for 24 years, and as a leading global meeting, it is the ideal event to announce our latest product updates. In particular the introduction of the AV-S MRI ventilator is an exciting milestone for Penlon and represents our continued commitment to a product development programme for the MRI environment.”
Every four years the World Federation of Societies of Anaesthesiologists (WFSA) and a member National Society host the World Congress of Anaesthesiologists (WCA). The WCA takes place 28 August – 2 September 2016 and will be held in Hong Kong, hosted by the Society of Anaesthetists of Hong Kong (SAHK) at the Hong Kong Convention and Exhibition Centre. Attracting delegates from over 125 countries the WCA has a unique global reach and diversity and offers an outstanding scientific and social experience for all who attend.
Penlon is a long established medical device company, with headquarters and manufacturing facilities based in Abingdon, UK. The key areas of business are Anaesthesia, Intubation, Suction and Oxygen Therapy and are supported by our experienced Technical Service team. Penlon supplies high quality medical devices to leading healthcare institutes in over 90 countries worldwide.